Current Pharmacogenomics and Personalized Medicine
Title:Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?)
Volume: 10 Issue: 2
Author(s): Gillian Bartlett, Nathalie Zgheib, Aresha Manamperi, Wei Wang, Candan Hızel, Rabia Kahveci and Yasemin Yazan
Affiliation:
Keywords: Developing countries, developing world genomics, essential medicines, genomics and international development, global personalized medicine, pharmacogenomics and primary care, primary care genomics, public health pharmacogenomics
Export Options
About this article
Cite this article as:
Bartlett Gillian, Zgheib Nathalie, Manamperi Aresha, Wang Wei, Hızel Candan, Kahveci Rabia and Yazan Yasemin, Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?), Current Pharmacogenomics and Personalized Medicine 2012; 10 (2) . https://dx.doi.org/10.2174/187569212800626430
DOI https://dx.doi.org/10.2174/187569212800626430 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Nanotechnology Approaches for Targeted Cancer Therapy
Recent Patents on Nanomedicine A Series of 2,4(1H,3H)-Quinazolinedione Derivatives: Synthesis and Biological Evaluation as Potential Anticancer Agents
Letters in Drug Design & Discovery Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design The Epidemiology of Sepsis
Current Pharmaceutical Design Polycation-Based Gene Therapy: Current Knowledge and New Perspectives
Current Gene Therapy Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach
Anti-Cancer Agents in Medicinal Chemistry The Roles of Corticotropin Releasing Factor (CRF) in Responses to Emotional Stress: Is CRF Release a Cause or Result of Fear/Anxiety?
CNS & Neurological Disorders - Drug Targets Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery
Current Pharmaceutical Design Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Current Pharmaceutical Design Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Current Pharmacogenomics Therapeutic Monoclonal Antibodies: Strategies and Challenges for Biosimilars Development
Current Medicinal Chemistry Factors Associated with Pulmonary Embolism Recurrence and the Benefits of Long-term Anticoagulant Therapy
Cardiovascular & Hematological Disorders-Drug Targets From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Current Pharmaceutical Design On the Role of Rab5 in Cell Migration
Current Molecular Medicine Better Targeting Melanoma: Options Beyond Surgery and Conventional Chemotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets
Current Pharmaceutical Design Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
Current Topics in Medicinal Chemistry Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
Current Pharmaceutical Biotechnology Recent Applications of Triazolopyrimidine-Based Bioactive Compounds in Medicinal and Agrochemical Chemistry
Mini-Reviews in Medicinal Chemistry